" /> Peroxisome biogenesis disorder 5a (zellweger) - CISMeF





Preferred Label : Peroxisome biogenesis disorder 5a (zellweger);

Symbol : PBD5A;

CISMeF acronym : CGF; CG10; CG5; PBD5A;

Type : Phenotype, molecular basis known;

Included titles and symbols : Peroxisome biogenesis disorder, complementation group 5; Peroxisome biogenesis disorder, complementation group 10; Peroxisome biogenesis disorder, complementation group f; CG5; CG10; CGF;

Description : The peroxisomal biogenesis disorder (PBD) Zellweger syndrome (ZS) is an autosomal recessive multiple congenital anomaly syndrome. Affected children present in the newborn period with profound hypotonia, seizures, and inability to feed. Characteristic craniofacial anomalies, eye abnormalities, neuronal migration defects, hepatomegaly, and chondrodysplasia punctata are present. Children with this condition do not show any significant development and usually die in the first year of life (summary by Steinberg et al., 2006). For a complete phenotypic description and a discussion of genetic heterogeneity of Zellweger syndrome, see 214100. Individuals with PBDs of complementation group 5 (CG5, equivalent to CG10 and CGF) have mutations in the PEX2 gene. For information on the history of PBD complementation groups, see 214100.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the peroxisome biogenesis factor 2 gene (PEX2, 170993.0001);

Laboratory abnormalities : Absent peroxisomes in skin fibroblasts; Accumulation of very-long-chain fatty acids in serum;

Prefixed ID : #614866;

Details


You can consult :


Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.